205 related articles for article (PubMed ID: 2175014)
1. Effects of chronic pindolol treatment on human myocardial beta 1- and beta 2-adrenoceptor function.
Bjørnerheim R; Golf S; Hansson V
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):429-35. PubMed ID: 2175014
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic amiodarone treatment on human myocardial beta adrenoceptor density and adenylate cyclase response.
Bjørnerheim R; Frøysaker T; Hansson V
Cardiovasc Res; 1991 Jun; 25(6):503-9. PubMed ID: 1653643
[TBL] [Abstract][Full Text] [Related]
3. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
4. Regulation of beta-adrenoceptors in the guinea pig left ventricle and skeletal muscle following chronic agonist treatment.
Elfellah MS; Reid JL
Eur J Pharmacol; 1990 Jul; 182(2):387-92. PubMed ID: 1975785
[TBL] [Abstract][Full Text] [Related]
5. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
6. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
7. Independent sensitization of beta-adrenoceptors and adenylate cyclase in acute myocardial ischaemia.
Strasser RH; Marquetant R; Kübler W
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):27S-35S. PubMed ID: 1980079
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
Schumacher C; Becker H; Conrads R; Schotten U; Pott S; Kellinghaus M; Sigmund M; Schöndube F; Preusse C; Schulte HD
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):398-407. PubMed ID: 7630430
[TBL] [Abstract][Full Text] [Related]
9. Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation.
Golf S; Hansson V
Cardiovasc Res; 1986 Sep; 20(9):637-44. PubMed ID: 2878724
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor adenylate cyclase system adaptation to physical training in rat ventricular tissue.
Plourde G; Rousseau-Migneron S; Nadeau A
J Appl Physiol (1985); 1991 Apr; 70(4):1633-8. PubMed ID: 1647390
[TBL] [Abstract][Full Text] [Related]
11. Regulation of beta 1- and beta 2-adrenoceptors following chronic treatment with beta-adrenoceptor antagonists.
Elfellah MS; Reid JL
Eur J Pharmacol; 1989 Nov; 173(1):85-92. PubMed ID: 2575041
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.
Chatelain P; Meysmans L; Mattéazzi JR; Beaufort P; Clinet M
Br J Pharmacol; 1995 Oct; 116(3):1949-56. PubMed ID: 8640331
[TBL] [Abstract][Full Text] [Related]
13. Control of cultured epithelial (MDCK) cell transport function: identification of a beta-adrenoceptor coupled to adenylate cyclase.
Rugg EL; Simmons NL
Q J Exp Physiol; 1984 Apr; 69(2):339-53. PubMed ID: 6328561
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms underlying reduced beta 2-adrenoceptor responsiveness in lymphocytes from neonates and old subjects.
O'Hara N; Daul AE; Fesel R; Siekmann U; Brodde OE
Mech Ageing Dev; 1985; 31(2):115-22. PubMed ID: 2997551
[TBL] [Abstract][Full Text] [Related]
15. Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system.
Freissmuth M; Schütz W; Weindlmayer-Göttel M; Zimpfer M; Spiss CK
J Cardiovasc Pharmacol; 1987 Nov; 10(5):568-74. PubMed ID: 2447407
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.
Freissmuth M; Tuisl E; Steurer G; Schütz W
Eur J Pharmacol; 1984 Sep; 104(1-2):169-72. PubMed ID: 6094208
[TBL] [Abstract][Full Text] [Related]
17. The relationship between beta-adrenoceptor regulation and beta-adrenergic responsiveness in hepatocytes. Studies on acquisition, desensitization and resensitization of isoproterenol-sensitive adenylate cyclase in primary culture.
Refsnes M; Sandnes D; Christoffersen T
Eur J Biochem; 1987 Mar; 163(3):457-66. PubMed ID: 3030743
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
Warner AL; Bellah KL; Raya TE; Roeske WR; Goldman S
Circulation; 1992 Nov; 86(5):1584-95. PubMed ID: 1330362
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract.
Abraham G; Kottke C; Dhein S; Ungemach FR
Biochem Pharmacol; 2003 Sep; 66(6):1067-81. PubMed ID: 12963495
[TBL] [Abstract][Full Text] [Related]
20. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
